These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

729 related items for PubMed ID: 23116773

  • 1. Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.
    White JP, Gao S, Puppa MJ, Sato S, Welle SL, Carson JA.
    Mol Cell Endocrinol; 2013 Jan 30; 365(2):174-86. PubMed ID: 23116773
    [Abstract] [Full Text] [Related]

  • 2. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF, Yan X, Zhu MJ, Du M.
    J Cell Biochem; 2009 Oct 01; 108(2):458-68. PubMed ID: 19639604
    [Abstract] [Full Text] [Related]

  • 3. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
    Sanchez AM, Csibi A, Raibon A, Cornille K, Gay S, Bernardi H, Candau R.
    J Cell Biochem; 2012 Feb 01; 113(2):695-710. PubMed ID: 22006269
    [Abstract] [Full Text] [Related]

  • 4. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
    White JP, Puppa MJ, Gao S, Sato S, Welle SL, Carson JA.
    Am J Physiol Endocrinol Metab; 2013 May 15; 304(10):E1042-52. PubMed ID: 23531613
    [Abstract] [Full Text] [Related]

  • 5. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy.
    Basualto-Alarcón C, Jorquera G, Altamirano F, Jaimovich E, Estrada M.
    Med Sci Sports Exerc; 2013 Sep 15; 45(9):1712-20. PubMed ID: 23470307
    [Abstract] [Full Text] [Related]

  • 6. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA, Hirase T, Hudoyo AW, Cheng J, Toyama K, Morisaki H, Morisaki T.
    BMC Endocr Disord; 2015 Mar 27; 15():11. PubMed ID: 25887856
    [Abstract] [Full Text] [Related]

  • 7. Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats.
    Luo L, Lu AM, Wang Y, Hong A, Chen Y, Hu J, Li X, Qin ZH.
    Exp Gerontol; 2013 Apr 27; 48(4):427-36. PubMed ID: 23419688
    [Abstract] [Full Text] [Related]

  • 8. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
    Nishimura Y, Chunthorng-Orn J, Lord S, Musa I, Dawson P, Holm L, Lai YC.
    Am J Physiol Cell Physiol; 2022 Jul 01; 323(1):C215-C225. PubMed ID: 35704697
    [Abstract] [Full Text] [Related]

  • 9. Androgens induce growth of the limb skeletal muscles in a rapamycin-insensitive manner.
    Rossetti ML, Fukuda DH, Gordon BS.
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct 01; 315(4):R721-R729. PubMed ID: 29897818
    [Abstract] [Full Text] [Related]

  • 10. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
    Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ.
    Am J Physiol Cell Physiol; 2009 Jun 01; 296(6):C1258-70. PubMed ID: 19357233
    [Abstract] [Full Text] [Related]

  • 11. Protective Effect of Pyropia yezoensis Peptide on Dexamethasone-Induced Myotube Atrophy in C2C12 Myotubes.
    Lee MK, Choi JW, Choi YH, Nam TJ.
    Mar Drugs; 2019 May 11; 17(5):. PubMed ID: 31083497
    [Abstract] [Full Text] [Related]

  • 12. Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.
    Pöllänen E, Ronkainen PH, Horttanainen M, Takala T, Puolakka J, Suominen H, Sipilä S, Kovanen V.
    Growth Horm IGF Res; 2010 Oct 11; 20(5):372-9. PubMed ID: 20724185
    [Abstract] [Full Text] [Related]

  • 13. GLP-2 ameliorates D-galactose induced muscle aging by IGF-1/Pi3k/Akt/FoxO3a signaling pathway in C2C12 cells and mice.
    Ye YL, Kuai Z, Qian DD, He YT, Shen JP, Wu KF, Ren WY, Hu Y.
    Arch Gerontol Geriatr; 2024 Sep 11; 124():105462. PubMed ID: 38692155
    [Abstract] [Full Text] [Related]

  • 14. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.
    Sandri M, Barberi L, Bijlsma AY, Blaauw B, Dyar KA, Milan G, Mammucari C, Meskers CG, Pallafacchina G, Paoli A, Pion D, Roceri M, Romanello V, Serrano AL, Toniolo L, Larsson L, Maier AB, Muñoz-Cánoves P, Musarò A, Pende M, Reggiani C, Rizzuto R, Schiaffino S.
    Biogerontology; 2013 Jun 11; 14(3):303-23. PubMed ID: 23686362
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
    Wang DT, Yin Y, Yang YJ, Lv PJ, Shi Y, Lu L, Wei LB.
    Int Immunopharmacol; 2014 Apr 11; 19(2):206-13. PubMed ID: 24534773
    [Abstract] [Full Text] [Related]

  • 16. Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.
    Gao S, Carson JA.
    Am J Physiol Cell Physiol; 2016 Jan 01; 310(1):C66-79. PubMed ID: 26491045
    [Abstract] [Full Text] [Related]

  • 17. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.
    Frost RA, Huber D, Pruznak A, Lang CH.
    J Cell Biochem; 2009 Dec 01; 108(5):1192-202. PubMed ID: 19795384
    [Abstract] [Full Text] [Related]

  • 18. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ.
    Curr Top Microbiol Immunol; 2010 Dec 01; 346():267-78. PubMed ID: 20593312
    [Abstract] [Full Text] [Related]

  • 19. The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.
    Mori S, Nada S, Kimura H, Tajima S, Takahashi Y, Kitamura A, Oneyama C, Okada M.
    PLoS One; 2014 Dec 01; 9(2):e88891. PubMed ID: 24558442
    [Abstract] [Full Text] [Related]

  • 20. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
    Chen L, Chen L, Wan L, Huo Y, Huang J, Li J, Lu J, Xin B, Yang Q, Guo C.
    Oncol Rep; 2019 Aug 01; 42(2):479-494. PubMed ID: 31233199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.